Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | ET | NSC |
|---|---|---|
| Price | $20.49 | $313.26 |
| Change today | ▼ 0.02% | ▼ 0.56% |
| Market cap | $70.54B | $70.36B |
| Return, 3 months | +10.0% | +3.5% |
| Return, year to date | +30.9% | +9.9% |
| Return, 1 year | +26.5% | +8.7% |
| P/E (TTM) | 14.0 | 26.7 |
| P/B | 2.0 | 4.3 |
| P/E percentile vs own 5y | 86th | 82nd |
| Dividend yield | 6.52% | 1.72% |
| Revenue growth (YoY, latest qtr) | +78.4% | +11.4% |
| Net profit growth (YoY) | +73.5% | -4.4% |
| Gross margin | 17.9% | 35.5% |
| Operating margin | 10.3% | 36.4% |
| Net margin | 4.7% | 21.0% |
| Return on equity | 14.4% | 17.0% |
| Analyst target vs. price | +21.4% | +17.8% |
| Analyst buy share | 86% | 33% |
| RSI (14) | 42 | 37 |
| 30-day volatility | 15.7% | 18.2% |
| Max drawdown, 1 year | -8.0% | -12.5% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.